ZEHRA ESSANI
Prescription History 1215607239
Nurse Practitioner - Family in Birmingham, AL

Active since September 20, 2021PECOS EnrolledAccepts Medicare Assignment
625 19TH ST S # JT845, BIRMINGHAM, AL 35233(205) 934-4696(205) 934-9118 Get Directions

NPPES record last updated: September 20, 2021. Verified against the NPPES registry weekly; last sync: October 18, 2026.

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for ZEHRA ESSANI, an active Family specialist practicing in Birmingham, AL. Our medical registry currently tracks 1 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 18 documented patient claims. Among these therapy options, the most frequently utilized medication is Aprepitant, which accounts for 18 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

1
Medication
18
Total Claims
18
30-Day Fills
Aprepitant
Most Prescribed · 18 claims
View details
1 medication · 2024 Medicare Part D
Medicare Part D medications prescribed by ZEHRA ESSANI in 2024, with prescription volumes, average cost per fill, and AL state comparisons
Medication Prescriptions (2024)Rx (2024) Avg Cost per FillCost / Fill Vs. Other AL PrescribersVs. AL Avg
Aprepitant18$46.83▼ below AL avg▼ Less than typical

About Aprepitant: Aprepitant is used with other medications to help prevent nausea and vomiting caused by cancer drug treatment (chemotherapy). Show more ▾

Aprepitant works by blocking one of the body's natural substances (substance P/neurokinin 1) that causes vomiting. This medication will not treat nausea or vomiting that has already started. Ask your doctor what you should do if you already have nausea or vomiting. A morpholine neurokinin-1 (NK1) receptor antagonist that is used in the management of nausea and vomiting caused by DRUG THERAPY, and for the prevention of POSTOPERATIVE NAUSEA AND VOMITING.

In 2024, this provider wrote 18 Medicare prescriptions for Aprepitant, about half the volume of the typical Alabama prescriber of this medication (32.7). Medicare paid an average of $46.83 per fill, versus $434.34 statewide.

How often this provider prescribes it

This provider
18
AL average
32.7

This provider prescribes this medication less often than the average AL prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$46.83
AL average
$434.34

This provider's average cost per fill is below the AL average for this medication.

18
30-Day Fills
standardized to 30-day supplies
24
Days of Medication
total across all patients in 2024
No medications match the current filters.
▲ More than typical≈ Typical▼ Less than typical= prescription volume vs the average AL prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the AL average cost per fill.

About this data. The prescription history for ZEHRA ESSANI is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Family prescribing approach at this Birmingham, AL practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among AL prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.

About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.